Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Long non-coding RNAs (LncRNAs) are key regulators in various cancers.
• Cancer susceptibility candidate 15 (CASC15) is implicated in melanoma progression.
• The precise roles and mechanisms of CASC15 in melanoma remain unclear.

Purpose of the Study:

• To investigate the function and molecular mechanisms of CASC15 in melanoma.
• To explore the potential of CASC15 as a therapeutic target for melanoma.

Main Methods:

• Analysis of CASC15 expression in melanoma tissues.
• In vitro functional experiments (knockdown and overexpression) in melanoma cells.
• Mechanistic studies involving EZH2, H3K27me3, and PDCD4.
• In vivo tumor growth assays.

Main Results:

• CASC15 expression is elevated in melanoma tissues and correlates with advanced stages.
• CASC15 knockdown inhibits proliferation, induces apoptosis, and suppresses invasion.
• CASC15 epigenetically silences PDCD4 by recruiting EZH2 and increasing H3K27me3.
• PDCD4 overexpression reverses the pro-tumorigenic effects of CASC15.
• CASC15 depletion inhibits tumor growth in vivo by upregulating PDCD4.

Conclusions:

• CASC15 functions as an oncogene in melanoma by downregulating PDCD4 via the EZH2/H3K27me3 pathway.
• The CASC15/EZH2/PDCD4 axis represents a potential therapeutic target for melanoma intervention.